Jianmin Fang, Ph.D. Chairman, and CEO

  • Ph.D. from Dalhousie University, Post-Doctorate from Harvard University
  • Distinguished expert in “China 1000 Expert Plan”
  • Distinguished expert in Shandong Province “Taishan Scholar Project”
  • Expert member of National Major Science and Technology project “China National Create Significant New Drugs”(National 13/5 Plan)
  • Professor at Tongji University, Shanghai, China
  • Years of experience on monoclonal antibodies in the United States
  • Over 20 patents, including the inventor of IND Conbercept

Qibin Liang, President 

  • Over 23 years in management in the biopharmaceutical industry working under the cGMP environment
  • More than 20 years of experience with large multinational companies such as Genentech, Bayer, Tanox
  • Rich experience in bioreactors (continuous or intermittent) from small to large and commercial scale, medium production, cell line separation, protein separation and purification, process management of disc centrifuge and fill/finish

James Ruan, Ph. D., VP, Quality

  • Ph.D. from Lund University, Post-Doctorate from UCLA
  • Over 30 years experience in monoclonal antibody research and quality management
  • Member of Scandinavian Society of Immunology
  • Member of Parenteral Drug Association
  • Holds two international invention patents

Andrew C. Huang, Ph.D.,VP, R&D

  • Ph.D. from the University of Iowa, Post-Doctorate from UCLA
  • Distinguished expert in Shandong Province “Taishan Scholar Project”
  • Over 20 years research experience in Biopharmaceuticals in the United States
  • More than 25 years experience in molecular medicine

Yong Deng, VP, Admin & HR

  • BSc. from Shandong University of TCM, Senior Economist
  • Over 20 years management in pharmaceutical enterprise, keen insight in corporate development
  • Rich experience in marketing strategy, corporate operation, and capital management